BioStem Technologies, Inc. (OTCMKTS:BSEM) Short Interest Up 32.3% in January

BioStem Technologies, Inc. (OTCMKTS:BSEM) was the target of a significant increase in short interest during the month of January. As of January 30th, there was short interest totaling 406,408 shares, an increase of 32.3% from the January 15th total of 307,219 shares. Based on an average daily volume of 495,453 shares, the short-interest ratio is currently 0.8 days. Approximately 2.4% of the shares of the company are sold short. Approximately 2.4% of the shares of the company are sold short. Based on an average daily volume of 495,453 shares, the short-interest ratio is currently 0.8 days.

BioStem Technologies Price Performance

OTCMKTS BSEM opened at $5.72 on Wednesday. The business’s fifty day moving average is $5.02 and its 200-day moving average is $5.37. The stock has a market capitalization of $96.13 million, a price-to-earnings ratio of 6.72 and a beta of -0.38. BioStem Technologies has a one year low of $3.09 and a one year high of $15.74.

About BioStem Technologies

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr.